首页> 美国卫生研究院文献>Canadian Medical Association Journal >Plasma exchange in the long-term management of Waldenströms macroglobulinemia.
【2h】

Plasma exchange in the long-term management of Waldenströms macroglobulinemia.

机译:Waldenström巨球蛋白血症的长期治疗中的血浆置换。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Two patients with Waldenström's macroglobulinemia (WM), which had become resistant to cytotoxic drugs, were treated for features of the hyperviscosity syndrome by repeated plasma exchange with the continuous-flow blood-cell separator over periods of 36 and 28 months, respectively. After four initial weekly plasma exchanges the procedure was carried out every 4 to 6 weeks and both patients tolerated it well. Relative viscosity of the serum was maintained within the normal range in one patient, and both patients remained free of symptoms of the hyperviscosity syndrome. The results suggest that treatment of WM by long-term "maintenance" plasma exchange alone should be considered in any patient with complications due to chemotherapy or whose disease fails to respond to chemotherapy.
机译:两名已经对细胞毒性药物产生耐药性的Waldenström巨球蛋白血症(WM)的患者,通过分别在36和28个月内用连续流血细胞分离器反复进行血浆置换来治疗高粘度综合征的特征。在最初的每周四次血浆置换后,该过程每4至6周进行一次,两名患者均耐受良好。一名患者的血清相对粘度维持在正常范围内,并且两名患者均未出现高粘综合征的症状。结果表明,对于任何因化疗引起并发症或疾病对化疗无反应的患者,应考虑仅通过长期“维持”血浆置换治疗WM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号